The way I see this is simple:
Current share price doesn't reflect the current development of science we own. Many valuations are saying $31.00+
If you add another rare disease to the mix, this valuation will increase the new valuation.
If you add in 3 more positive breakthroughs, the share valuation would be in excess of $100.00.
So, if the current share price is $22.57, there is certainly only extreme upside. We are trading in profit, we expect these profits to grow exponentially and with new disease being treated, the current share price has a very long way to go, to get to a point of stabilisation.
For me, it's one of the most simple stock picks around to generate further profits.
xoxo
Merry Christmas all.
Take Over Opportunity
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.48 |
Change
-0.480(2.29%) |
Mkt cap ! $2.650B | |||
| Open | High | Low | Value | Volume |
| $21.00 | $21.21 | $20.31 | $2.251M | 108.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 284 | $20.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.49 | 302 | 4 |
View Market Depth
| Last trade - 11.10am 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$20.64 |
Change
-0.480 ( 2.00 %) |
||||
| Open | High | Low | Volume | ||
| $20.97 | $21.15 | $20.32 | 40446 | ||
| Last updated 11.28am 30/05/2024 ? | |||||
| NEU (ASX) Chart |